Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1687-1694

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, H. O.
Right arrow Articles by Nordestgaard, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, H. O.
Right arrow Articles by Nordestgaard, B. G.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Restenosis
Right arrow Animal models of human disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1687-1694.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Effect of Cyclosporine on Arterial Balloon Injury Lesions in Cholesterol-Clamped Rabbits

T Lymphocyte–Mediated Immune Responses Not Involved in Balloon Injury–Induced Neointimal Proliferation

Henrik Ørbæk Andersen; Birgit Fischer Hansen; Pernille Holm; Steen Stender; Børge Grønne Nordestgaard

From the Department of Thoracic Surgery (H.Ø.A.), Rigshospitalet, National University Hospital, Copenhagen; the Department of Pathology (B.F.H.), Hvidovre University Hospital, Hvidovre; the Department of Women's Health Care Biology (P.H.), Novo Nordisk; the Department of Clinical Biochemistry (S.S.), Gentofte University Hospital, Gentofte; and the Department of Clinical Biochemistry (B.G.N.), Glostrup University Hospital, Glostrup, Denmark.

Correspondence to Dr H.Ø. Andersen, Department of Thoracic Surgery, 2152 Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.

Abstract—Restenosis after balloon dilatation of stenosed coronary arteries is a major clinical problem. Because T lymphocytes occur in neointima and because cyclosporine inhibits T-lymphocyte proliferation, we tested the hypothesis that cyclosporine would attenuate neointimal proliferation after balloon dilation injury. Rabbits with a balloon-injured aorta, randomized to cyclosporine in the human therapeutic range (n=13) or vehicle (n=14) were followed up for 5 weeks; as a control for the effect of cyclosporine, half the rabbits received in addition an aorta allograft. Rabbits were clamped at a human plasma cholesterol level of 5 to 7 mmol/L. Cyclosporine did not affect aorta cholesterol accumulation or neointimal proliferation in balloon-injured aortas; however, it attenuated both in transplanted aortas. Likewise, cyclosporine had no effect on endothelial cells at balloon-injured sites, but protected these cells in the transplanted aortas. Infiltration of smooth muscle cells, T lymphocytes, and macrophages were unaffected by cyclosporine in balloon-injured aortas; however, in transplanted aortas, cyclosporine reduced the relative number of T lymphocytes and macrophages but increased the relative number of smooth muscle cells. Finally, in balloon-injured aortas, cyclosporine did not affect expression of vascular adhesion molecule-1, intercellular adhesion molecule-1, or major histocompatibility complex II, but all these cellular activation markers were attenuated by cyclosporine in transplanted aortas. These results suggest that cyclosporine does not attenuate neointimal proliferation after balloon dilatation, and that T lymphocyte—mediated immune responses are not involved in neointimal proliferation after balloon dilatation.


Key Words: balloon injury • restenosis • cyclosporine • endothelial activation • chronic rejection




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
P. Religa, K. Bojakowski, M. Bojakowska, Z. Gaciong, J. Thyberg, and U. Hedin
Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis
Cardiovasc Res, February 1, 2005; 65(2): 535 - 545.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Satonaka, E. Suzuki, H. Nishimatsu, S. Oba, R. Takeda, A. Goto, M. Omata, T. Fujita, R. Nagai, and Y. Hirata
Calcineurin Promotes the Expression of Monocyte Chemoattractant Protein-1 in Vascular Myocytes and Mediates Vascular Inflammation
Circ. Res., March 19, 2004; 94(5): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. A. Visner, F. Lu, H. Zhou, J. Liu, K. Kazemfar, and A. Agarwal
Rapamycin Induces Heme Oxygenase-1 in Human Pulmonary Vascular Cells: Implications in the Antiproliferative Response to Rapamycin
Circulation, February 18, 2003; 107(6): 911 - 916.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. D. Danenberg, F. G. P. Welt, M. Walker III, P. Seifert, G. S. Toegel, and E. R. Edelman
Systemic Inflammation Induced by Lipopolysaccharide Increases Neointimal Formation After Balloon and Stent Injury in Rabbits
Circulation, June 18, 2002; 105(24): 2917 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Zhu, C. A. Reardon, G. S. Getz, and D. Y. Hui
Both Apolipoprotein E and Immune Deficiency Exacerbate Neointimal Hyperplasia After Vascular Injury in Mice
Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 450 - 455.
[Abstract] [Full Text] [PDF]